Correction: Single-cell RNA-sequencing identifies anti-cancer immune phenotypes in the early lung metastatic niche during breast cancer (Clinical & Experimental Metastasis, (2022), 39, 6, (865-881), 10.1007/s10585-022-10185-4)

Sophia M. Orbach; Michael D. Brooks; Yining Zhang; Scott E. Campit; Grace G. Bushnell; Joseph T. Decker; Ryan J. Rebernick; Sriram Chandrasekaran; Max S. Wicha; Jacqueline S. Jeruss; Lonnie D. Shea

doi:10.1007/s10585-023-10215-9

Correction: Single-cell RNA-sequencing identifies anti-cancer immune phenotypes in the early lung metastatic niche during breast cancer (Clinical & Experimental Metastasis, (2022), 39, 6, (865-881), 10.1007/s10585-022-10185-4)

Sophia M. Orbach
, Michael D. Brooks
, Yining Zhang
, Scott E. Campit
, Grace G. Bushnell
, Joseph T. Decker
, Ryan J. Rebernick
, Sriram Chandrasekaran
, Max S. Wicha
, Jacqueline S. Jeruss
, Lonnie D. Shea

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Clinical & Experimental Metastasis (2022) 39:865–881 In the original publication of this article, the Acknowledgements section was published incorrectly. The correct Acknowledgements section is given in this correction. Acknowledgements Funds for this research were provided by the National Institutes of Health (NIH) R01 CA243916 (L.D.S and J.S.J.), NIH R01 CA214384 (L.D.S and J.S.J.), and NIH R35 CA197585 (M.S.W.). Further support was provided by the Dynami Foundation, the Breast Cancer Research Foundation (BCRF-18-173), and A Sister’s Hope. S.M.O is funded through the UM Postdoctoral Translational Scholar Program and NRSA F32 CA243421. S.E.C is a recipient of the Advanced Proteome Informatics of Cancer Training Program T32 CA140044. J.T.D. is funded through the NIH 5K01 EB028877. G.G.B is a recipient of the NRSA F31 CA224982. The original article has been corrected.

Original language	English (US)
Pages (from-to)	373
Number of pages	1
Journal	Clinical and Experimental Metastasis
Volume	40
Issue number	4
DOIs	https://doi.org/10.1007/s10585-023-10215-9
State	Published - Aug 2023
Externally published	Yes

Bibliographical note

Publisher Copyright:
© 2023, The Author(s), under exclusive licence to Springer Nature B.V.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Publisher link

10.1007/s10585-023-10215-9

Find It

Find It at U of M Libraries

Fingerprint

Dive into the research topics of 'Correction: Single-cell RNA-sequencing identifies anti-cancer immune phenotypes in the early lung metastatic niche during breast cancer (Clinical & Experimental Metastasis, (2022), 39, 6, (865-881), 10.1007/s10585-022-10185-4)'. Together they form a unique fingerprint.

Cite this

Orbach, S. M., Brooks, M. D., Zhang, Y., Campit, S. E., Bushnell, G. G., Decker, J. T., Rebernick, R. J., Chandrasekaran, S., Wicha, M. S., Jeruss, J. S., & Shea, L. D. (2023). Correction: Single-cell RNA-sequencing identifies anti-cancer immune phenotypes in the early lung metastatic niche during breast cancer (Clinical & Experimental Metastasis, (2022), 39, 6, (865-881), 10.1007/s10585-022-10185-4). Clinical and Experimental Metastasis, 40(4), 373. https://doi.org/10.1007/s10585-023-10215-9

Correction: Single-cell RNA-sequencing identifies anti-cancer immune phenotypes in the early lung metastatic niche during breast cancer (Clinical & Experimental Metastasis, (2022), 39, 6, (865-881), 10.1007/s10585-022-10185-4). / Orbach, Sophia M.; Brooks, Michael D.; Zhang, Yining et al.
In: Clinical and Experimental Metastasis, Vol. 40, No. 4, 08.2023, p. 373.

Research output: Contribution to journal › Comment/debate › peer-review

Orbach, SM, Brooks, MD, Zhang, Y, Campit, SE, Bushnell, GG, Decker, JT, Rebernick, RJ, Chandrasekaran, S, Wicha, MS, Jeruss, JS & Shea, LD 2023, 'Correction: Single-cell RNA-sequencing identifies anti-cancer immune phenotypes in the early lung metastatic niche during breast cancer (Clinical & Experimental Metastasis, (2022), 39, 6, (865-881), 10.1007/s10585-022-10185-4)', Clinical and Experimental Metastasis, vol. 40, no. 4, pp. 373. https://doi.org/10.1007/s10585-023-10215-9

Orbach SM, Brooks MD, Zhang Y, Campit SE, Bushnell GG, Decker JT et al. Correction: Single-cell RNA-sequencing identifies anti-cancer immune phenotypes in the early lung metastatic niche during breast cancer (Clinical & Experimental Metastasis, (2022), 39, 6, (865-881), 10.1007/s10585-022-10185-4). Clinical and Experimental Metastasis. 2023 Aug;40(4):373. doi: 10.1007/s10585-023-10215-9

@article{733df1367bdc4cfba492665d02ac0295,

title = "Correction: Single-cell RNA-sequencing identifies anti-cancer immune phenotypes in the early lung metastatic niche during breast cancer (Clinical \& Experimental Metastasis, (2022), 39, 6, (865-881), 10.1007/s10585-022-10185-4)",

abstract = "Clinical \& Experimental Metastasis (2022) 39:865{\textendash}881 In the original publication of this article, the Acknowledgements section was published incorrectly. The correct Acknowledgements section is given in this correction. Acknowledgements Funds for this research were provided by the National Institutes of Health (NIH) R01 CA243916 (L.D.S and J.S.J.), NIH R01 CA214384 (L.D.S and J.S.J.), and NIH R35 CA197585 (M.S.W.). Further support was provided by the Dynami Foundation, the Breast Cancer Research Foundation (BCRF-18-173), and A Sister{\textquoteright}s Hope. S.M.O is funded through the UM Postdoctoral Translational Scholar Program and NRSA F32 CA243421. S.E.C is a recipient of the Advanced Proteome Informatics of Cancer Training Program T32 CA140044. J.T.D. is funded through the NIH 5K01 EB028877. G.G.B is a recipient of the NRSA F31 CA224982. The original article has been corrected.",

author = "Orbach, \{Sophia M.\} and Brooks, \{Michael D.\} and Yining Zhang and Campit, \{Scott E.\} and Bushnell, \{Grace G.\} and Decker, \{Joseph T.\} and Rebernick, \{Ryan J.\} and Sriram Chandrasekaran and Wicha, \{Max S.\} and Jeruss, \{Jacqueline S.\} and Shea, \{Lonnie D.\}",

note = "Publisher Copyright: {\textcopyright} 2023, The Author(s), under exclusive licence to Springer Nature B.V.",

year = "2023",

month = aug,

doi = "10.1007/s10585-023-10215-9",

language = "English (US)",

volume = "40",

pages = "373",

journal = "Clinical and Experimental Metastasis",

issn = "0262-0898",

publisher = "Springer Science and Business Media B.V.",

number = "4",

}

TY - JOUR

T1 - Correction

T2 - Single-cell RNA-sequencing identifies anti-cancer immune phenotypes in the early lung metastatic niche during breast cancer (Clinical & Experimental Metastasis, (2022), 39, 6, (865-881), 10.1007/s10585-022-10185-4)

AU - Orbach, Sophia M.

AU - Brooks, Michael D.

AU - Zhang, Yining

AU - Campit, Scott E.

AU - Bushnell, Grace G.

AU - Decker, Joseph T.

AU - Rebernick, Ryan J.

AU - Chandrasekaran, Sriram

AU - Wicha, Max S.

AU - Jeruss, Jacqueline S.

AU - Shea, Lonnie D.

PY - 2023/8

Y1 - 2023/8

N2 - Clinical & Experimental Metastasis (2022) 39:865–881 In the original publication of this article, the Acknowledgements section was published incorrectly. The correct Acknowledgements section is given in this correction. Acknowledgements Funds for this research were provided by the National Institutes of Health (NIH) R01 CA243916 (L.D.S and J.S.J.), NIH R01 CA214384 (L.D.S and J.S.J.), and NIH R35 CA197585 (M.S.W.). Further support was provided by the Dynami Foundation, the Breast Cancer Research Foundation (BCRF-18-173), and A Sister’s Hope. S.M.O is funded through the UM Postdoctoral Translational Scholar Program and NRSA F32 CA243421. S.E.C is a recipient of the Advanced Proteome Informatics of Cancer Training Program T32 CA140044. J.T.D. is funded through the NIH 5K01 EB028877. G.G.B is a recipient of the NRSA F31 CA224982. The original article has been corrected.

AB - Clinical & Experimental Metastasis (2022) 39:865–881 In the original publication of this article, the Acknowledgements section was published incorrectly. The correct Acknowledgements section is given in this correction. Acknowledgements Funds for this research were provided by the National Institutes of Health (NIH) R01 CA243916 (L.D.S and J.S.J.), NIH R01 CA214384 (L.D.S and J.S.J.), and NIH R35 CA197585 (M.S.W.). Further support was provided by the Dynami Foundation, the Breast Cancer Research Foundation (BCRF-18-173), and A Sister’s Hope. S.M.O is funded through the UM Postdoctoral Translational Scholar Program and NRSA F32 CA243421. S.E.C is a recipient of the Advanced Proteome Informatics of Cancer Training Program T32 CA140044. J.T.D. is funded through the NIH 5K01 EB028877. G.G.B is a recipient of the NRSA F31 CA224982. The original article has been corrected.

UR - https://www.scopus.com/pages/publications/85163099599

UR - https://www.scopus.com/pages/publications/85163099599#tab=citedBy

U2 - 10.1007/s10585-023-10215-9

DO - 10.1007/s10585-023-10215-9

M3 - Comment/debate

C2 - 37310520

AN - SCOPUS:85163099599

SN - 0262-0898

VL - 40

SP - 373

JO - Clinical and Experimental Metastasis

JF - Clinical and Experimental Metastasis

IS - 4

ER -

Correction: Single-cell RNA-sequencing identifies anti-cancer immune phenotypes in the early lung metastatic niche during breast cancer (Clinical & Experimental Metastasis, (2022), 39, 6, (865-881), 10.1007/s10585-022-10185-4)

Abstract

Bibliographical note

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this